Autoantibodies against cytokines and their role in the pathogenesis of viral infections

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037320

Enrollment

515

Registered

2025-08-05

Start date

2025-09-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A85.8

Interventions

Group 1: Retrospective cohorts with confirmed viral infections (BoDV-1, herpes simplex encephalitis, herpes zoster) Group 2: Healthy control groups without infection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: archived serum (Institute for Clinical Microbiology and Hygiene, University Hospital Regensburg) from patients with evidence of the respective infectious disease (BoDV-1, TBE, HSV-1 encephalitis, herpes zoster), purely retrospective

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Frequency of autoantibodies against cytokines (e.g., typ I interferons)	—

Countries

Germany

Contacts

Public ContactMarkus Bauswein

Universitätsklinikum Regensburg, Insitut für Klinische Mikrobiologie und Hygiene

markus.bauswein@ukr.de+49 941 944 14635

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026